IPILIMUMAB for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 264 adverse event reports in the FDA FAERS database where IPILIMUMAB was used for Prostate cancer.
Most Reported Side Effects for IPILIMUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 3,710 | 10.2% | 3,709 | 285 |
| Malignant neoplasm progression | 3,296 | 9.0% | 1,570 | 1,538 |
| Diarrhoea | 2,557 | 7.0% | 305 | 1,643 |
| Off label use | 2,097 | 5.7% | 528 | 731 |
| Colitis | 1,988 | 5.4% | 293 | 1,229 |
| Pyrexia | 1,796 | 4.9% | 237 | 1,336 |
| Rash | 1,556 | 4.3% | 162 | 694 |
| Fatigue | 1,447 | 4.0% | 176 | 776 |
| Intentional product use issue | 1,329 | 3.6% | 563 | 347 |
| Nausea | 1,169 | 3.2% | 139 | 773 |
| Decreased appetite | 990 | 2.7% | 136 | 665 |
| Immune-mediated enterocolitis | 988 | 2.7% | 73 | 504 |
| Hypophysitis | 981 | 2.7% | 61 | 515 |
| Dyspnoea | 906 | 2.5% | 165 | 651 |
| Pneumonitis | 891 | 2.4% | 220 | 560 |
Other Indications for IPILIMUMAB
Malignant melanoma (8,903)
Product used for unknown indication (4,980)
Metastatic malignant melanoma (4,430)
Non-small cell lung cancer (2,987)
Renal cell carcinoma (2,585)
Metastatic renal cell carcinoma (1,826)
Non-small cell lung cancer recurrent (1,089)
Lung neoplasm malignant (530)
Small cell lung cancer (474)
Pleural mesothelioma malignant (473)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)